Is Achilles Therapeutics plc (ACHL) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Achilles Therapeutics plc (NASDAQ:ACHL) is a good investment right now.
Achilles Therapeutics Plc (ACHL)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 0 | $0 | 0% | |
| 2. | Redmile Group Jeremy Green | 0 | $0 | 0% | |
| 3. | Vestal Point Capital Ryan Wilder | 0 | $0 | 0% | |
| 4. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,753 | $45,514 | 0.03% | |
| 2. | 4,480 | $6,629 | 0% | |
| 3. | 806 | $1,193 | 0% |
News See All
Hedge Fund Resource Center